We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Pharma Mar, S.A.

Avda. de Los Reyes 1, Poligono Industrial La Mina, 28770 Colmenar Viejo, Madrid, Spain
Telephone: +44 20 36 08 29 47 - Customer service for purchase
Telephone: +34 918 46 60 00
Fax: +34 91 846 60 04
E-mail: customers-gb@pharmamar.com - Customer service for
Medical Information Direct Line: 07554223176
Medical Information e-mail: uk@medinfopharmamar.com
Medical Information Facsimile: +34 91 846 60 04
Stock Availability: +34 91 823 45 33
Patient Information Leaflet last updated on medicines.ie: 14/11/2017
PIL Yondelis 0.25 mg powder for concentrate for solution for infusion/Yondelis 1 mg powder for concentrate for solution for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 14/11/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Updated on 29/08/2017 and displayed until 14/11/2017
Reasons for adding or updating:
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Updated on 21/07/2016 and displayed until 29/08/2017
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
  • Change to dosage and administration
Updated on 26/01/2016 and displayed until 21/07/2016
Reasons for adding or updating:
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to date of revision
Updated on 02/07/2015 and displayed until 26/01/2016
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
  • Removal of black triangle
Updated on 11/08/2014 and displayed until 02/07/2015
Reasons for adding or updating:
  • Addition of information on reporting a side effect.
Updated on 04/06/2014 and displayed until 11/08/2014
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
  • Change to date of revision
Updated on 20/03/2014 and displayed until 04/06/2014
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 31/07/2013 and displayed until 20/03/2014
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
  • Addition of black triangle
Updated on 01/03/2013 and displayed until 31/07/2013
Reasons for adding or updating:
  • Change to date of revision
  • Change to dosage and administration
Updated on 17/08/2012 and displayed until 01/03/2013
Reasons for adding or updating:
  • Change of contraindications
  • Change to storage instructions
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to further information section
  • Change to improve clarity and readability
Updated on 08/02/2012 and displayed until 17/08/2012
Reasons for adding or updating:
  • Change to further information section
  • Change to information about driving or using machinery
  • Change to date of revision
  • Change to dosage and administration
  • Change of contraindications
  • Change to storage instructions
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 01/06/2011 and displayed until 08/02/2012
Reasons for adding or updating:
  • Change to further information section
  • Change to date of revision
Updated on 10/11/2009 and displayed until 01/06/2011
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to further information section
  • Change to date of revision
  • Change to dosage and administration
  • Changes to therapeutic indications
  • Change of special precautions for disposal
Updated on 29/07/2009 and displayed until 10/11/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to further information section
Updated on 30/04/2009 and displayed until 29/07/2009
Reasons for adding or updating:
  • Change to further information section
  • Change to date of revision
  • Change to dosage and administration
Updated on 19/02/2008 and displayed until 30/04/2009
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Trabectedin